The exciting news from the folks at MathStar, a fabless semiconductor company specializing in high-performance programmable logic, is that they've been selected by VisionGate to help develop this potentially groundbreaking medical imaging solution for cellular characterization employing 3D computed tomographic scanning on intact cells from patients at risk of cancer.

After extensive evaluation and benchmarking against other computing architectures, VisionGate selected MathStar's Arrix Field Programmable Object Array (FPOA) chip as the processing engine for its Cell-CT platform, which is entering investigational clinical trials.

"We are pleased to be working with VisionGate, the leading innovator in 3D diagnostic cellular imaging," said Doug Pihl, MathStar's CEO. "MathStar's FPOA technology is uniquely suited for the needs of high-performance medical imaging applications."

Dr. Alan Nelson, VisionGate's chairman and CEO, said, "MathStar's FPOA architecture provides the performance and flexibility to implement the computationally demanding filtering and backprojection algorithms we employ in our 3D imaging technology. We are excited to collaborate with MathStar as we advance our Cell-CT platform through clinical studies and toward product commercialization worldwide."

MathStar's investment in the medical-imaging market includes a portfolio of digital signal processing (DSP) libraries, FPOA development software, and an FPOA evaluation system for application development. The Arrix family is MathStar's second generation of high-performance, re-programmable FPOAs that are uniquely well suited for advanced medical-imaging and other performance-demanding applications.

For more information on the FPOA's use in medical imaging, visit www.mathstar.com/Medical.php.

For more information on VisionGate and the Cell-CT, please contact Rob Bateman at bateman@visiongate3d.com.